Research ties insulin to higher mortality risk in diabetes

01/14/2013 | FoodConsumer.org

Type 2 diabetes patients who were on insulin treatment had an 89% higher risk of all-cause mortality and 116% higher risk of cancer-related death than nonusers, a study revealed. However, researchers noted diabetes patients on insulin did not have a higher overall risk of cancer. The findings appear in PLoS One.

View Full Article in:

FoodConsumer.org

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC